UNC lab partnership develops first COVID-19 treatment approved by FDA

Posted Nov 7, 2020
Remdesivir, a drug developed through a partnership between UNC’s Baric Lab and Gilead Sciences, was recently approved as a COVID-19 treatment. As of Oct. 22, remdesivir is the first and only FDA-approved COVID-19 treatment in the U.S. UNC faculty and students reflected on the significance of remdesivir’s approval and what this means for the University. (Daily Tar Heel)

Related: Campus Connections

Excellence Unveiled: Karsen Kitchen
In the sixth installment of Excellence Unveiled, listen to Karsen Kitchen, class of 2025, discuss her 20-minute journey aboard a Blue Origin rocket and her...
Sat Jul 12, 2025

Coker Arboretum provides tranquility, history
At the intersection of East Cameron Avenue and Raleigh Street lies the Coker Arboretum, a lush green escape from the rest of UNC’s bustling campus...
Thu Jul 10, 2025

UNC ranked No. 3 best value public university by Princeton Review
UNC-Chapel Hill is ranked the No. 3 best value public university in the nation in The Princeton Review’s list of Best Value Colleges for 2025,...
Wed Jul 9, 2025

Orange County Hit Hard by Tropical Storm Chantal
More than 10 inches of rain fell in a matter of hours and rivers and creeks surged. In Chapel Hill, Morgan Creek exceeded flood stage...
Tue Jul 8, 2025